期刊文献+

Dickkopf-1在胶原诱导性关节炎大鼠外周血中的水平及与关节炎症的关系 被引量:2

Peripheral blood levels and relationship to joint inflammation of Dickkopf-1 in collagen induced arthritis rats
原文传递
导出
摘要 目的观察Dickkophl(DKKl)在胶原诱导性关节炎(CIA)大鼠外周血中的水平,探讨其与关节炎症的关系。方法建立CIA大鼠关节炎模型,分为模型组、对照组,采用足爪容积、关节炎指数(AI)评价关节炎症;酶联免疫吸附试验(ELISA)法检测血清中DKK1、骨保护素和肿瘤坏死因子(TNF)-α水平;魏氏法检测红细胞沉降率(ESR),免疫比浊法检测C反应蛋白(CRP)。采用t检验、方差分析、秩和检验和相关分析进行统计学处理。结果模型组大鼠足爪容积大于对照组(模型组:2.01±0.21,对照组:1.55±0.11),差异有统计学意义(t=77.139,P=O.000);模型组大鼠在造模后每周AI值逐渐增加(分别为7.20±0.25,10.64±2.18,12.81±1.82),差异有统计学意义(F=17.736,P〈0.05);模型组在造模后1、2、3周血清DKK1水平分别为(60±15),(73±16),(82±20)pg/ml,明显高于对照组[(20±9)pg/ml,F=45.866,P=O.000];模型组在造模后1、2、3周血清TNF-α分别为(221±102),(300±87),(344±70)pg/ml,明显高于对照组[(101±38)pg/ml,F=27.689,P=0.000];模型组在造模后1、2、3周血清骨保护素水平分别为(240±168),(130±61),(71±37)pg/ml,明显低于对照组[(450±147)pg/mt],差异有统计学意义(F=255.29,P:0.000)。相关性分析显示模型组大鼠血清DKKI与AI、TNF-α呈正相关(r值分别为0.428、0.513,P〈0.05)。结论CIA大鼠血清DKK1水平可能与炎症相关,或许是通过TNF-α进行调控的。 Objective To observe the peripheral blood levels of Dickkopf-1 (DKK1) in collagen induced arthritis (CIA) rats, and to explore the relationship with joint inflammation. Methods CIA rats were randomly divided into 3 model groups and 3 control groups, joint inflammation were assessed by paw volume and arthritis index (AI). Serum levels of DKK1, osteoprotegerin (OPG) and tumor necrosis factor-alpha (TNF-α) were measured by enzyme linked immunosorbent assay (ELISA). Erythrocyte sedimentation rate (ESR) was detected by Westergren method, while C-reactive protein (CRP) was tested by immunoturbidi- metry. T test, analysis of variance, rank sum test, and correlation analysis were used for statistic analysis. Results Paw volume was significantly enlarged in the model groups (2.01±0.21 vs 1.55±0.11, t=77.139, P=-0.000). The AI score of the model groups was gradually increased weekly, the difference was statistically significant (7.20±0.25, 10.64±2.18, 12.81±1.82, respectively; F=17.736, P〈0.05). After modeling for 1, 2, 3 weeks, the serum levels of DKK1 in the models were (60±15), (73±16), 82±20) pg/ml respectively, which were signi-ficantly higher than those of the controls (20±9) pg/ml (F=45.866, P=0.000), TNF-α in the models were (221±102), (300±87), (344±87) pg/ml respectively, which were significantly higher than controls (101 ±38) pg/ml (F=27.689, P=0.000), the ESR and CRP in the models were also significantly higher than those of the controls, while OPG in the models were (240±168), (130±61), (71±37) pg/ml respectively, which were significantly lower than the controls (450±147) pg/ml, the differences of above parameters between the two groups were all statistically significant (F=255.29, P=-0.000). Correlation analysis showed that the serum levels of DKK1 in the model group and AI, TNF-α were positively correlated, the correlation coefficients were 0.428 and 0.513, respectively, the difference was statistically significant (P〈 0.05). Conclusion Serum levels of DKK1 in the CIA rats may be associated with inflammation, which may be regulated through TNF-α.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第10期685-688,共4页 Chinese Journal of Rheumatology
基金 上海市卫生局中医药科研基金(2012QL043A) 上海市中医药事业发展三年行动计划(ZYSNXD-CCZDYJ054) 上海市长宁区卫生局科研课题(20114Q03001)
关键词 关节炎 实验性 炎症 DICKKOPF-1 Arthritis, experimental Inflammation Dickkopf-1
  • 相关文献

参考文献6

二级参考文献129

  • 1Van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JR Breedveld FC. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol 1993; 20: 1288-1296.
  • 2Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-361.
  • 3Van der Heijde DM, van Riel PL, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Putte LB. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients. Br J Rheumatol 1992; 31 : 519-525.
  • 4Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43: 250-258.
  • 5Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor r,B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000; 43: 259-269.
  • 6Romas E, Bakharevski O, Hards DK, Kartsogiannis V, Quinn JM, Ryan PF, et al. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 2000; 43: 821-826.
  • 7Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM. Osteoprotegerin and receptor activator of nuclear factor κB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 2001; 40: 623-630.
  • 8Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 397: 315-323.
  • 9Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268.
  • 10Hase H, Kanno Y, Kojima H, Sakurai D, Kobata T. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin. Arthritis Rheum 2008; 58: 3356-3365.

共引文献73

同被引文献16

  • 1Ji G, Zhang Y, Yang Q, et al. Genistein suppresses LPS-induced inflammatory response through inhibiting NF-kB fol-lowing AMP kinase activation in RAW 264.7 macrophages [J].PLoS One, 2012, 7(12): e53101. DOI: 10.1371/joumal.pone.0053101.
  • 2Dowling RJ,Goodwin PJ,Stambolic V. Understanding the bene-fit of metformin use in cancer treatment [J]. BMC Med, 2011, 9:33. DOI: 10.1186/1741-7015-9-33.
  • 3Sun Y, Tian T,Gao J, et al. Metformin ameliorates the develop-ment of experimental autoimmune encephalomyelitis by regulatingT helper 17 and regulatory T cells in mice[J]. J Neuroimmunol,2016,292: 58 67. DOI: 10.1016/j.jneuroim.2016.01.014.
  • 4Lee SY,Lee SH, Yang EJ, et al. Metformin ameliorates inflam-matory bowel disease by suppression of the STAT3 signalingpathway and regulation of the between Thl7/Treg balance [J].PLoS One, 2015, 10(9): e0135858. DOI: 10.1371/joumal.pone.0135858.
  • 5Wasko MC, Kay J, Hsia EC,et al. Diabetes mellitus and insulinresistance in patients with rheumatoid arthritis: risk reduction ina chronic inflammatory disease[J]. Arthritis Care Res (Hoboken),2011, 63(4): 512-521. DOI: 10.1002/acr.20414.
  • 6Solomon DH, Massarotti E, Garg R, et al. Association betweendisease-modifying antirheumatic drugs and diabetes risk in pa-tients with rheumatoid arthritis and psoriasis[J]. JAMA, 2011,305(24): 2525-2531. DOI: 10.1001/jama.2011.878.
  • 7Kang KY, Kim YK,Yi H, et al. Metformin downregulates Thl7cells differentiation and attenuates murine autoimmune arthritis[J]. Int Immunopharmacol. 2013,16.(1): 85-92. DOI: 10.1016/j.intimp.2013.03.020.
  • 8Hawley SA, Gadalla AE,Olsen GS, et al. The antidiabetic drugmetformin activates the AMP-activated protein kinase cascadevia an adenine nucleotide-independent mechanism[J]. Diabetes,2002,51(8): 2420-2425.
  • 9Son HJ,Lee J, Lee SY, et al. Metformin attenuates exper-imental autoimmune arthritis through reciprocal regulation ofThl7/Treg balance and osteoclastogenesis [J]. Mediators Inflamm,2014,2014: 973986. DOI: 10.1155/2014/973986.
  • 10Michalek RD, Gerriets VA, Jacobs SR, et al. Cutting edge: dis-tinct glycolytic and lipid oxidative metabolic programs are essen-tial for effector and regulatory CD4+ T cell subsets[J]. J Immunol,2011,186(6): 3299-3303. DOI: 10.4049/jimmunol.l003613.

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部